Anti-Doping / Clean Climbing

The UIAA promotes Clean Climbing by adopting and implementing the World Anti-Doping (WADA) Programme in its entirety. In parallel, the UIAA is responsible for ensuring that all of its member associations and athletes respect and comply with all relevant International Standards and all the principles inherent to the World-Anti Doping Code, including registered testing pool and the doping violation procedure.


The UIAA’s clean climbing animation

Committed to Clean Climbing


On 18 October 2014, the UIAA General Assembly adopted the latest amendments to the UIAA Anti-Doping policy. The policy was now harmonised with the 2014 World Anti-Doping Code.

These anti-doping rules were first adopted by the UIAA General Assembly on 11 October 2003 in Berchtesgaden, Germany. Various other amendments were added by the UIAA General Assembly on 16 October 2004 in New Delhi, India when it was agreed: “That the UIAA General Assembly gives power to the UIAA Board to approve interim amendments to UIAA Anti-Doping Policy and Procedure.”

The UIAA is committed to fair play, a sport free of doping and the principles of the Code. The UIAA has adopted the World Anti-Doping Code (2009); this includes the mandatory articles of the Code and all relevant International Standards.

As a consequence, UIAA officials, representatives, member associations and athletes in UIAA-organised or approved events are expected to conduct themselves in a manner that is appropriate for an international federation of sport and in accordance with Anti-Doping Policy and Procedure. Failure to observe the anti-doping policy and procedure shall result in a disciplinary procedure and sanctions.

The aims of the UIAA’s Anti-Doping Policy and Procedure are to:

  • Promote drug-free competitions in UIAA-recognised sports.
  • Develop fair and consistent anti-doping procedures and regulations.
  • Assist Member Associations in meeting their obligations to their national sports authorities and comply with relevant national legislation (such as in the field of contracts, human rights, and data protection).

The UIAA & Anti-Doping

UIAA & Anti-Doping Code

Anti-Doping News


The UIAA abides by the World Anti-Doping (WADA) standard for testing and testing procedures. Athletes participating in UIAA approved competitions, and other competitions run by UIAA member associations, are responsible for complying with the World Anti-Doping Code (“the Code”) and all relevant International Standards. All athletes have a right to enjoy competitions that are properly organised under rules that aim to ensure fairness and prevent doping.

Member Associations are responsible for complying with the Code and the UIAA Anti-Doping Policy and Procedure. Member Associations will make agreements in writing with athletes that confirms the athletes’ support for the Anti-Doping Policy and Procedure and the other UIAA rules and regulations.

All athletes affiliated with a National Federation shall be subject to in-competition testing by the UIAA, the athlete’s national federation, and any other Anti-Doping Organisation responsible for testing at a competition or event in which they participate. All athletes affiliated with a national federation shall also be subject to out-of-competition testing at any time or place, with or without advance notice, by the UIAA, WADA, the athlete’s national federation, the national anti-doping organisation of any country where the athlete is present.

UIAA Ice Climbing


The International Standard for Granting Therapeutic Use Exemptions (TUEs) developed by the World Anti-Doping Agency provides the framework for athletes to use ‘medicines on the ‘Prohibitive List’ to treat legitimate medical conditions.

This is important because athletes, like everyone else, may suffer from illnesses (for example, asthma) that require them to take particular medications. Provided that the need for medications is genuine, and subject to specific criteria, the use of medications should not impact on the ability of athletes to play sport. Athletes that have a duly authorised TUE will not be considered to have committed an Anti-Doping rule violation following a positive test result for the approved medication so long as the conditions of the TUE were fully met.

All glucocorticosteroids are prohibited when administered by oral, intravenous, intramuscular or rectal routes. Administration of glucocorticosteroids by systemic rout is an indication for standard TUE application.

All beta-2 agonists (including both optical isomers where relevant) are prohibited except salbutamol (maximum 1600 micrograms over 24 hours) and salmeterol when taken by inhalation in accordance with the manufacturers’ recommended therapeutic regime. The presence of salbutamol in urine in excess of 1000 ng/mL is presumed not to be an intended therapeutic use of the substance and will be considered as an Adverse Analytical Finding unless the Athlete proves, through a controlled pharmacokinetic study, that the abnormal result was the consequence of the use of a therapeutic dose (maximum 1600 micrograms over 24 hours) of inhaled salbutamol.

The TUE standard is an integral part of the International Convention against Doping in Sport because it is fundamental to international harmonization in the fight against doping in sport. Adherence to this standard ensures that the process for granting TUEs is the same across all sports organizations and countries.



UIAA affirms the belief of WADA & UNESCO that education is a central theme of any programme designed to remove doping from sports. A successful programme of anti-doping worldwide can only function with adequate education of athletes and the whole sporting community. The UIAA firmly believes that athletes and their support system should be well aware of all rights, obligations, anti-doping precautions, methods, doping control systems and prohibitive substances. It also reiterates that athletes should be aware of consequences of doping not just in terms of doping code violations and disciplinary measures thereof, but also about the health hazards caused due to doping substances.

The UIAA with help of WADA and other anti-doping agencies will raise awareness about anti-doping in the mountaineering community. UIAA and its member associations are committed to provide the ideal environment for ‘fair play’ and educate every member of the mountaineering community about the harm from doping to the sport and the individual(s) concerned.

The WADA website provides a number of resources designed to help athletes understand the dangers and consequences of doping, as well as their responsibilities under the World Anti-Doping Code (Code).



The UIAA Anti-Doping Commission assists member associations to implement the Code and the Anti-Doping Policy and Procedure. It adopts and implements the World Anti-Doping (WADA) Programme in its entirety and is responsible for ensuring that all its member associations and athletes respect and comply with the Code, all relevant International Standards and all the principles inherent to the Code. “On 18 October 2014, the UIAA General Assembly adopted the latest amendments to the UIAA Anti Doping policy. The policy was now harmonized with the 2014 World Anti-Doping Code.”


  • Develop and maintain UIAA doping control program including in and out of competition testing, result based testing, random testing and targeted testing.
  • Establish and maintain the Registered Testing Pool (RTP), identifying those who need provide their whereabouts.
  • Development and maintenance of UIAA Anti Doping Policy and Procedure and ensure compliance with the WADA code.
  • Develop UIAA Anti-Doping education and information programme for all stakeholders (Coordinate education with Member Association and NADOs. Focus education for Member Countries with lo recognition of NADO).
  • Member Association education and assist in implementation of UIAA
  • Anti Doping Policy and Procedure
  • Producing an annual report on UIAA Anti-Doping activities
  • WADA and NADO communication

Anti Doping Commission Membership

As confirmed by the Management Committee in Brixen (Bressanone), Italy (October 2016)


Nenad DIKIC (President), Serbia (PSS)

Marija ANDJELKOVIC, Serbia (PSS)

Borja Osés GARCIA, Spain (EMF)

Jaladin SHAHBAZI, Iran (I.R.IMF)


Enrico DONEGANI, Italy (CAI)

Verma RAKESH, India (IMF)

UIAA Executive Board Link

Thomas KAHR

Sign up to our Newsletter